Streetwise Live! Presents Cross River Ventures on 07/28/2021. Learn More

CytoDyn Inc.

CYDY:OTCQB

Last:
Change: Change(%):
Volume: Open:
High: Low:
52Wk High: 52Wk Low:

CytoDyn is a biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab (PRO 140), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 appears to play a key role in the ability of HIV to enter and infect healthy T-cells.